Eylem Levelt Selected Research

ECHO protocol

1/2021

A comparison of liver fat fraction measurement on MRI at 3T and 1.5T.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eylem Levelt Research Topics

Disease

10	Heart Failure 10/2022 - 01/2017
4	Type 2 Diabetes Mellitus (MODY) 12/2021 - 10/2017
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 11/2014
3	Diabetic Cardiomyopathies 11/2021 - 12/2016
3	Fibrosis (Cirrhosis) 05/2021 - 01/2017
2	Heart Diseases (Heart Disease) 01/2022 - 04/2018
2	Cicatrix (Scar) 01/2022 - 01/2021
2	Cardiomyopathies (Cardiomyopathy) 11/2021 - 01/2017
2	Left Ventricular Dysfunction 01/2021 - 01/2017
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2017 - 11/2016
1	Infections 10/2022
1	Inflammation (Inflammations) 11/2021
1	Heart Valve Diseases (Valvular Heart Disease) 11/2021
1	ST Elevation Myocardial Infarction 01/2021
1	Ventricular Remodeling 01/2021
1	Hypertrophy 01/2019
1	Liver Diseases (Liver Disease) 04/2018
1	Hypertension (High Blood Pressure) 10/2017
1	Pathologic Constriction (Stenosis) 10/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Atrial Fibrillation 10/2016
1	Obesity 01/2016
1	Insulin Resistance 01/2016
1	Aortic Valve Stenosis (Aortic Stenosis) 11/2014
1	Hyperemia 11/2014

Drug/Important Bio-Agent (IBA)

6	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 11/2014
4	GadoliniumIBA 01/2021 - 11/2014
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 01/2017
2	Sodium-Glucose Transport ProteinsIBA 12/2021 - 05/2021
2	Phosphorus (Red Phosphorus)IBA 11/2021 - 11/2016
2	Triglycerides (Triacylglycerol)IBA 12/2018 - 01/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 10/2022
1	Mineralocorticoid Receptor AntagonistsIBA 10/2022
1	Angiotensin Receptor AntagonistsIBA 10/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2021
1	empagliflozinIBA 12/2021
1	ferric oxide (iron oxide)IBA 11/2021
1	TESIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	VildagliptinIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 10/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	CytokinesIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 12/2016
1	Vasodilator Agents (Vasodilators)IBA 11/2014

Therapy/Procedure

5	Therapeutics 10/2022 - 04/2018
1	Glycemic Control 05/2021
1	ECHO protocol 01/2021
1	Cardiac Resynchronization Therapy 01/2021
1	Catheter Ablation 10/2016